» Articles » PMID: 38792534

Challenges of Managing Type 3c Diabetes in the Context of Pancreatic Resection, Cancer and Trauma

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 May 25
PMID 38792534
Authors
Affiliations
Soon will be listed here.
Abstract

Type 3c diabetes mellitus (T3cDM), also known as pancreatogenic or pancreoprivic diabetes, is a specific type of DM that often develops as a result of diseases affecting the exocrine pancreas, exhibiting an array of hormonal and metabolic characteristics. Several pancreatic exocrine diseases and surgical procedures may cause T3cDM. Diagnosing T3cDM remains difficult as the disease characteristics frequently overlap with clinical presentations of type 1 DM (T1DM) or type 2 DM (T2DM). Managing T3cDM is likewise challenging due to numerous confounding metabolic dysfunctions, including pancreatic endocrine and exocrine insufficiencies and poor nutritional status. Treatment of pancreatic exocrine insufficiency is of paramount importance when managing patients with T3cDM. This review aims to consolidate the latest information on surgical etiologies of T3cDM, focusing on partial pancreatic resections, total pancreatectomy, pancreatic cancer and trauma.

Citing Articles

The Significance of Comprehensive Metabolic Phenotypes in Cancer Risk: A Japan Multi-Institutional Collaborative Cohort Study.

Watanabe T, Nguyen T, Katsuura-Kamano S, Arisawa K, Ishizu M, Unohara T Cancer Res Commun. 2024; 4(11):2986-2997.

PMID: 39470380 PMC: 11579844. DOI: 10.1158/2767-9764.CRC-24-0249.


Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics.

Asaad G, Doghish A, Rashad A, El-Dakroury W Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39453501 DOI: 10.1007/s00210-024-03532-7.

References
1.
Hart P, Andersen D, Mather K, Castonguay A, Bajaj M, Bellin M . Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic.... Pancreas. 2018; 47(10):1239-1243. PMC: 6195331. DOI: 10.1097/MPA.0000000000001168. View

2.
Matveyenko A, Dry S, Cox H, Moshtaghian A, Gurlo T, Galasso R . Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes. 2009; 58(7):1604-15. PMC: 2699878. DOI: 10.2337/db09-0058. View

3.
Wynne K, Devereaux B, Dornhorst A . Diabetes of the exocrine pancreas. J Gastroenterol Hepatol. 2018; 34(2):346-354. DOI: 10.1111/jgh.14451. View

4.
Raghavan S, Ballehaninna U, Chamberlain R . The impact of perioperative blood glucose levels on pancreatic cancer prognosis and surgical outcomes: an evidence-based review. Pancreas. 2013; 42(8):1210-7. DOI: 10.1097/MPA.0b013e3182a6db8e. View

5.
Shah O, Robbani I, Nazir P, Khan A . Central pancreatectomy: a new technique for resection of selected pancreatic tumors. Hepatobiliary Pancreat Dis Int. 2009; 8(1):93-6. View